Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

Allscripts Healthcare Solutions

Nasdaq:MDRX
Snowflake Description

Fair value with moderate growth potential.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
MDRX
Nasdaq
$1B
Market Cap
  1. Home
  2. US
  3. Healthcare
Company description

Allscripts Healthcare Solutions, Inc. provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. The last earnings update was 32 days ago. More info.


Add to Portfolio Compare Print
  • Allscripts Healthcare Solutions has significant price volatility in the past 3 months.
MDRX Share Price and Events
7 Day Returns
-2.1%
NasdaqGS:MDRX
2.4%
US Healthcare Services
-4.1%
US Market
1 Year Returns
-33.3%
NasdaqGS:MDRX
16.3%
US Healthcare Services
-14.9%
US Market
MDRX Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Allscripts Healthcare Solutions (MDRX) -2.1% -15.7% -33% -33.3% -48.2% -47.5%
US Healthcare Services 2.4% -4.3% -2.4% 16.3% 61.9% 36.3%
US Market -4.1% -19.1% -23.4% -14.9% 3.5% 14.5%
1 Year Return vs Industry and Market
  • MDRX underperformed the Healthcare Services industry which returned 16.3% over the past year.
  • MDRX underperformed the Market in United States of America which returned -14.9% over the past year.
Price Volatility
MDRX
Industry
5yr Volatility vs Market
Related Companies

MDRX Value

 Is Allscripts Healthcare Solutions undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Allscripts Healthcare Solutions to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Allscripts Healthcare Solutions.

NasdaqGS:MDRX Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 16 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 9.9%
Perpetual Growth Rate 10-Year US Government Bond Rate 1.7%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for NasdaqGS:MDRX
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year US Govt Bond Rate 1.7%
Equity Risk Premium S&P Global 5.4%
Healthcare Services Unlevered Beta Simply Wall St/ S&P Global 0.98
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.975 (1 + (1- 21%) (98.52%))
1.492
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
1.49
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 1.74% + (1.492 * 5.44%)
9.85%

Discounted Cash Flow Calculation for NasdaqGS:MDRX using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Allscripts Healthcare Solutions is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

Note: Free cash flow to equity valuations ignore the company's cash or debt.

NasdaqGS:MDRX DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (USD, Millions) Source Present Value
Discounted (@ 9.85%)
2020 84.58 Analyst x5 76.99
2021 117.58 Analyst x5 97.43
2022 120.15 Analyst x2 90.63
2023 149.95 Analyst x2 102.96
2024 196.30 Analyst x1 122.69
2025 222.36 Est @ 13.27% 126.51
2026 244.18 Est @ 9.81% 126.47
2027 262.23 Est @ 7.39% 123.63
2028 277.17 Est @ 5.7% 118.95
2029 289.67 Est @ 4.51% 113.16
Present value of next 10 years cash flows $1,099.00
NasdaqGS:MDRX DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2029 × (1 + g) ÷ (Discount Rate – g)
= $289.67 × (1 + 1.74%) ÷ (9.85% – 1.74%)
$3,631.67
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= $3,631.67 ÷ (1 + 9.85%)10
$1,418.77
NasdaqGS:MDRX Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= $1,099.00 + $1,418.77
$2,517.77
Equity Value per Share
(USD)
= Total value / Shares Outstanding
= $2,517.77 / 162.70
$15.47
NasdaqGS:MDRX Discount to Share Price
Calculation Result
Value per share (USD) From above. $15.47
Current discount Discount to share price of $6.45
= -1 x ($6.45 - $15.47) / $15.47
58.3%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Allscripts Healthcare Solutions is available for.
Intrinsic value
>50%
Share price is $6.45 vs Future cash flow value of $15.47
Current Discount Checks
For Allscripts Healthcare Solutions to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Allscripts Healthcare Solutions's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • Allscripts Healthcare Solutions's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Allscripts Healthcare Solutions's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Allscripts Healthcare Solutions's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
NasdaqGS:MDRX PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-12-31) in USD $-1.10
NasdaqGS:MDRX Share Price ** NasdaqGS (2020-04-02) in USD $6.45
United States of America Healthcare Services Industry PE Ratio Median Figure of 12 Publicly-Listed Healthcare Services Companies 39.64x
United States of America Market PE Ratio Median Figure of 2,944 Publicly-Listed Companies 12.5x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Allscripts Healthcare Solutions.

NasdaqGS:MDRX PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NasdaqGS:MDRX Share Price ÷ EPS (both in USD)

= 6.45 ÷ -1.10

-5.89x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Allscripts Healthcare Solutions is loss making, we can't compare its value to the US Healthcare Services industry average.
  • Allscripts Healthcare Solutions is loss making, we can't compare the value of its earnings to the United States of America market.
Price based on expected Growth
Does Allscripts Healthcare Solutions's expected growth come at a high price?
Raw Data
NasdaqGS:MDRX PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -5.89x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 16 Analysts
158.4%per year
United States of America Healthcare Services Industry PEG Ratio Median Figure of 11 Publicly-Listed Healthcare Services Companies 3.11x
United States of America Market PEG Ratio Median Figure of 2,008 Publicly-Listed Companies 0.91x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Allscripts Healthcare Solutions, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Allscripts Healthcare Solutions's assets?
Raw Data
NasdaqGS:MDRX PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-12-31) in USD $7.91
NasdaqGS:MDRX Share Price * NasdaqGS (2020-04-02) in USD $6.45
United States of America Healthcare Services Industry PB Ratio Median Figure of 38 Publicly-Listed Healthcare Services Companies 3.36x
United States of America Market PB Ratio Median Figure of 5,142 Publicly-Listed Companies 1.22x
NasdaqGS:MDRX PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NasdaqGS:MDRX Share Price ÷ Book Value per Share (both in USD)

= 6.45 ÷ 7.91

0.82x

* Primary Listing of Allscripts Healthcare Solutions.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Allscripts Healthcare Solutions is good value based on assets compared to the US Healthcare Services industry average.
X
Value checks
We assess Allscripts Healthcare Solutions's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare Services industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare Services industry average (and greater than 0)? (1 check)
  5. Allscripts Healthcare Solutions has a total score of 3/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

MDRX Future Performance

 How is Allscripts Healthcare Solutions expected to perform in the next 1 to 3 years based on estimates from 16 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
158.4%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Allscripts Healthcare Solutions expected to grow at an attractive rate?
  • Allscripts Healthcare Solutions's earnings growth is expected to exceed the low risk savings rate of 1.7%.
Growth vs Market Checks
  • Allscripts Healthcare Solutions's earnings growth is expected to exceed the United States of America market average.
  • Allscripts Healthcare Solutions's revenue growth is positive but not above the United States of America market average.
Annual Growth Rates Comparison
Raw Data
NasdaqGS:MDRX Future Growth Rates Data Sources
Data Point Source Value (per year)
NasdaqGS:MDRX Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 16 Analysts 158.4%
NasdaqGS:MDRX Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 16 Analysts 3.4%
United States of America Healthcare Services Industry Earnings Growth Rate Market Cap Weighted Average 23.8%
United States of America Healthcare Services Industry Revenue Growth Rate Market Cap Weighted Average 14.4%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 12.2%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7.1%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
NasdaqGS:MDRX Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 16 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
NasdaqGS:MDRX Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2024-12-31 2,182 1
2023-12-31 2,091 360 -1 3
2022-12-31 1,917 334 -8 8
2021-12-31 1,835 290 17 16
2020-12-31 1,777 220 -12 16
2020-04-03
NasdaqGS:MDRX Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-12-31 1,772 46 -182
2019-09-30 1,763 20 -197
2019-06-30 1,751 -1 -203
2019-03-31 1,748 15 34
2018-12-31 1,750 68 17
2018-09-30 1,516 188 70
2018-06-30 1,533 237 54
2018-03-31 1,518 262 -187
2017-12-31 1,498 279 -183
2017-09-30 1,714 257 -210
2017-06-30 1,657 246 -191
2017-03-31 1,618 269 -48

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Allscripts Healthcare Solutions's earnings are expected to grow significantly at over 20% yearly.
  • Allscripts Healthcare Solutions's revenue is expected to grow by 3.4% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
NasdaqGS:MDRX Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 16 Analyst Estimates (S&P Global) See Below

All data from Allscripts Healthcare Solutions Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NasdaqGS:MDRX Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2024-12-31
2023-12-31 -0.01 -0.01 -0.01 1.00
2022-12-31 -0.06 -0.06 -0.06 1.00
2021-12-31 0.13 0.50 -0.16 11.00
2020-12-31 -0.06 0.23 -0.53 10.00
2020-04-03
NasdaqGS:MDRX Past Financials Data
Date (Data in USD Millions) EPS *
2019-12-31 -1.10
2019-09-30 -1.16
2019-06-30 -1.19
2019-03-31 0.20
2018-12-31 0.10
2018-09-30 0.39
2018-06-30 0.30
2018-03-31 -1.04
2017-12-31 -1.01
2017-09-30 -1.16
2017-06-30 -1.05
2017-03-31 -0.26

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Allscripts Healthcare Solutions is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess Allscripts Healthcare Solutions's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Allscripts Healthcare Solutions has a total score of 3/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

MDRX Past Performance

  How has Allscripts Healthcare Solutions performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Allscripts Healthcare Solutions's growth in the last year to its industry (Healthcare Services).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Allscripts Healthcare Solutions does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Allscripts Healthcare Solutions's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Allscripts Healthcare Solutions's 1-year growth to the US Healthcare Services industry average as it is not currently profitable.
Earnings and Revenue History
Allscripts Healthcare Solutions's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Allscripts Healthcare Solutions Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NasdaqGS:MDRX Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-12-31 1,771.68 -182.18 419.77 244.51
2019-09-30 1,763.04 -196.77 405.23 247.69
2019-06-30 1,751.29 -203.18 412.20 256.85
2019-03-31 1,748.29 34.01 429.58 267.93
2018-12-31 1,749.96 17.20 449.27 268.41
2018-09-30 1,516.32 70.08 406.63 257.85
2018-06-30 1,533.33 53.63 415.86 245.87
2018-03-31 1,517.96 -187.35 404.98 217.84
2017-12-31 1,497.71 -182.96 400.69 202.28
2017-09-30 1,714.44 -209.59 451.27 194.58
2017-06-30 1,657.39 -191.19 432.69 188.67
2017-03-31 1,617.82 -47.68 415.46 190.10
2016-12-31 1,386.07 31.11 334.52 178.53
2016-09-30 1,470.11 -2.01 380.09 186.07
2016-06-30 1,432.20 2.93 362.35 188.63
2016-03-31 1,397.40 9.91 347.30 185.10
2015-12-31 1,386.39 -2.23 339.18 184.79
2015-09-30 1,381.65 -20.73 320.36 180.33
2015-06-30 1,372.56 -41.25 339.35 178.59
2015-03-31 1,372.14 -55.80 345.26 187.24
2014-12-31 1,377.87 -66.45 358.68 192.82
2014-09-30 1,387.95 -84.89 379.72 197.85
2014-06-30 1,372.75 -108.07 384.39 198.69
2014-03-31 1,366.28 -113.18 391.91 197.50
2013-12-31 1,373.06 -104.03 395.10 195.85
2013-09-30 1,373.05 -107.73 383.38 199.28
2013-06-30 1,403.55 -49.42 369.08 190.28

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Allscripts Healthcare Solutions has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Allscripts Healthcare Solutions has efficiently used its assets last year compared to the US Healthcare Services industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Allscripts Healthcare Solutions improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Allscripts Healthcare Solutions's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare Services industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Allscripts Healthcare Solutions has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

MDRX Health

 How is Allscripts Healthcare Solutions's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Allscripts Healthcare Solutions's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Allscripts Healthcare Solutions's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • Allscripts Healthcare Solutions's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Allscripts Healthcare Solutions's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is not covered by short term assets, assets are 0.9x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Allscripts Healthcare Solutions Company Filings, last reported 3 months ago.

NasdaqGS:MDRX Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-12-31 1,285.19 915.47 129.67
2019-09-30 1,281.06 913.44 129.35
2019-06-30 1,316.21 844.85 138.90
2019-03-31 1,456.12 786.76 137.17
2018-12-31 1,580.43 667.60 174.24
2018-09-30 1,584.66 1,814.29 111.78
2018-06-30 1,597.46 1,629.96 135.85
2018-03-31 1,553.80 1,711.44 135.00
2017-12-31 1,591.61 934.41 119.47
2017-09-30 1,567.08 1,400.25 104.30
2017-06-30 1,575.10 1,330.33 82.71
2017-03-31 1,587.62 1,310.08 104.39
2016-12-31 1,660.89 1,312.38 95.61
2016-09-30 1,747.91 1,210.07 77.25
2016-06-30 1,718.51 1,179.76 90.66
2016-03-31 1,389.27 599.53 100.12
2015-12-31 1,419.07 624.58 116.87
2015-09-30 1,395.58 654.40 91.40
2015-06-30 1,391.54 661.97 76.54
2015-03-31 1,278.09 572.48 88.48
2014-12-31 1,284.22 566.43 53.17
2014-09-30 1,282.83 586.95 37.35
2014-06-30 1,299.12 558.60 39.25
2014-03-31 1,307.62 548.77 41.58
2013-12-31 1,318.15 561.48 62.95
2013-09-30 1,331.03 544.29 60.79
2013-06-30 1,367.58 544.58 71.98
  • Allscripts Healthcare Solutions's level of debt (71.2%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (44.1% vs 71.2% today).
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Allscripts Healthcare Solutions has sufficient cash runway for 1.5 years based on current free cash flow.
  • Unable to confirm if Allscripts Healthcare Solutions has at least 1 year of cash runway based on growing free cash flows without relevant data.
X
Financial health checks
We assess Allscripts Healthcare Solutions's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Allscripts Healthcare Solutions has a total score of 2/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

MDRX Dividends

 What is Allscripts Healthcare Solutions's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Allscripts Healthcare Solutions dividends. Estimated to be 0% next year.
If you bought $2,000 of Allscripts Healthcare Solutions shares you are expected to receive $0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Allscripts Healthcare Solutions's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Allscripts Healthcare Solutions's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
NasdaqGS:MDRX Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 16 Analyst Estimates (S&P Global) See Below
Global Healthcare Services Industry Average Dividend Yield Market Cap Weighted Average of 29 Stocks 0.7%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 1941 Stocks 3.1%
United States of America Minimum Threshold Dividend Yield 10th Percentile 1.1%
United States of America Bottom 25% Dividend Yield 25th Percentile 2%
United States of America Top 25% Dividend Yield 75th Percentile 5.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

NasdaqGS:MDRX Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2024-12-31
2023-12-31
2022-12-31 0.00 3.00
2021-12-31 0.00 4.00
2020-12-31 0.00 4.00
2020-04-03

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Allscripts Healthcare Solutions has not reported any payouts.
  • Unable to verify if Allscripts Healthcare Solutions's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Allscripts Healthcare Solutions's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Allscripts Healthcare Solutions has not reported any payouts.
Future Payout to shareholders
  • No need to calculate the sustainability of Allscripts Healthcare Solutions's dividends in 3 years as they are not expected to pay a notable one for United States of America.
X
Income/ dividend checks
We assess Allscripts Healthcare Solutions's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.1%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Allscripts Healthcare Solutions afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Allscripts Healthcare Solutions has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

MDRX Management

 What is the CEO of Allscripts Healthcare Solutions's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Paul Black
COMPENSATION $7,801,251
AGE 61
TENURE AS CEO 7.3 years
CEO Bio

Mr. Paul M. Black has been the Chief Executive Officer of Allscripts Healthcare Solutions, Inc. since December 19, 2012. Mr. Black serves as an Adjunct Professor of Businss at the University of Missouri – Kansas City. He served as the President of Allscripts Healthcare Solutions, Inc. from December 19, 2012 to October 2015. Mr. Black served as a Senior Advisor at New Mountain Capital, LLC. He served as an Operating Executive at Genstar Capital, LLC. He spent 13 years at Cerner Corporation, where Mr. Black served as the Chief Sales Officer, an Executive Vice President of United States Client Organization, from 2003 to August 31, 2007 and served as the Chief Operating Officer, from February 2005 to August 31, 2007, with responsibility for operations and sales, technologies, managed services and intellectual property organizations. He joined Cerner Corp. in March of 1994 as a Regional Vice President. Mr. Black served as Senior Vice President and the Chief Sales Officer, since June 1998 and Executive Vice President, since September 2000. He served a number of positions for 12 years at International Business Machines Corporation (IBM), from 1982 to 1994, including as a Sales and Professional Services Branch Executive. Mr. Black has been the Chairman of Aris Teleradiology LLC, since December 2011. He serves as Director of Saepio Technologies, Inc. and eResearch Technology, Inc. Mr. Black serves on the Board of Directors of Biotronic NeuroNetwork. Mr. Black has been a Director of Allscripts Healthcare Solutions, Inc. since May 16, 2012, Netsmart Technologies, Inc. since January 31, 2011. He serves as a Member of the Board of Directors of Truman Medical Center, Inc. since 2001, Inmar Holdings Inc., Saepio Technologies, Inc., and Connextions, Inc. He served as a Director of Haemonetics Corporation since January 26, 2011. Mr. Black served as a Member of Chief Executive Officer Advisory Board of Great Point Partners, LLC, since 2011. He served as the Chairman of Truman Medical Center, Inc. Mr. Black has an MBA with emphasis in Marketing and Industrial Relations from the University of Iowa and a B.S. from Iowa State University.

CEO Compensation
  • Paul's compensation has increased whilst company is loss making.
  • Paul's remuneration is higher than average for companies of similar size in United States of America.
Management Team Tenure

Average tenure and age of the Allscripts Healthcare Solutions management team in years:

1.5
Average Tenure
55
Average Age
  • The average tenure for the Allscripts Healthcare Solutions management team is less than 2 years, this suggests a new team.
Management Team

Paul Black

TITLE
CEO & Director
COMPENSATION
$8M
AGE
61
TENURE
7.3 yrs

Rick Poulton

TITLE
President & CFO
COMPENSATION
$5M
AGE
54
TENURE
4.5 yrs

Brian Farley

TITLE
Executive VP
COMPENSATION
$3M
AGE
49
TENURE
2.7 yrs

Dennis Olis

TITLE
Executive Officer
COMPENSATION
$3M
AGE
56
TENURE
0.1 yrs

Lisa Khorey

TITLE
Executive VP & Chief Client Delivery Officer
COMPENSATION
$3M
AGE
52
TENURE
3.4 yrs

Joe Rostock

TITLE
Senior VP of Development & CTO
AGE
56
TENURE
0.1 yrs

Stephen Shulstein

TITLE
Vice President of Investor Relations
TENURE
1.8 yrs

Rich Elmore

TITLE
Senior Vice President of Corporate Development & Strategy
TENURE
1.3 yrs

Leah Jones

TITLE
Senior Vice President of Sales Operations
TENURE
1.3 yrs

Rebecca Whaley

TITLE
Vice President of Marketing
TENURE
0.1 yrs
Board of Directors Tenure

Average tenure and age of the Allscripts Healthcare Solutions board of directors in years:

4.3
Average Tenure
62.5
Average Age
  • The tenure for the Allscripts Healthcare Solutions board of directors is about average.
Board of Directors

Michael Klayko

TITLE
Chairman of the Board
COMPENSATION
$428K
AGE
64
TENURE
6.1 yrs

Paul Black

TITLE
CEO & Director
COMPENSATION
$8M
AGE
61
TENURE
8.3 yrs

David Stevens

TITLE
Independent Director
COMPENSATION
$303K
AGE
65
TENURE
8.3 yrs

Greg Garrison

TITLE
Independent Director
COMPENSATION
$305K
AGE
65
TENURE
4.8 yrs

Jon Judge

TITLE
Independent Director
COMPENSATION
$294K
AGE
65
TENURE
3.9 yrs

Yancey Spruill

TITLE
Independent Director
COMPENSATION
$273K
AGE
51
TENURE
3.9 yrs

Dave Stevens

TITLE
Independent Director
COMPENSATION
$272K
AGE
56
TENURE
3.9 yrs

Mara Aspinall

TITLE
Independent Director
COMPENSATION
$275K
AGE
57
TENURE
2.9 yrs
Who owns this company?
Recent Insider Trading
  • More shares have been bought than sold by Allscripts Healthcare Solutions individual insiders in the past 3 months.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
05. Mar 20 Buy Richard Poulton Individual 05. Mar 20 05. Mar 20 15,000 $7.40 $111,000
05. Mar 20 Buy Paul Black Individual 05. Mar 20 05. Mar 20 33,783 $7.47 $252,190
X
Management checks
We assess Allscripts Healthcare Solutions's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Allscripts Healthcare Solutions has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

MDRX News

Simply Wall St News

Is Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Trading At A 30% Discount?

A DCF is all about the idea that a dollar in the future is less valuable than a dollar today, so we need to discount the sum of these future cash flows to arrive at a present value estimate: 10-year free cash flow (FCF) estimate 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 Levered FCF ($, Millions) $106.2m $169.6m $180.5m $193.8m $205.0m $215.0m $224.1m $232.6m $240.7m $248.5m Growth Rate Estimate Source Analyst x6 Analyst x1 Analyst x1 Analyst x1 Est @ 5.8% Est @ 4.88% Est @ 4.23% Est @ 3.78% Est @ 3.47% Est @ 3.25% Present Value ($, Millions) Discounted @ 11.21% $95.5 $137.1 $131.2 $126.7 $120.6 $113.7 $106.6 $99.5 $92.5 $85.9 ("Est" = FCF growth rate estimated by Simply Wall St) Present Value of 10-year Cash Flow (PVCF)= $1.1b We now need to calculate the Terminal Value, which accounts for all the future cash flows after this ten year period. … In the same way as with the 10-year 'growth' period, we discount future cash flows to today's value, using a cost of equity of 11.2%. … Terminal Value (TV) = FCF2029 × (1 + g) ÷ (r – g) = US$248m × (1 + 2.7%) ÷ (11.2% – 2.7%) = US$3.0b Present Value of Terminal Value (PVTV) = TV / (1 + r)10 = $US$3.0b ÷ ( 1 + 11.2%)10 = $1.04b The total value, or equity value, is then the sum of the present value of the future cash flows, which in this case is $2.15b.

Simply Wall St -

Did Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Insiders Sell Shares?

So shareholders might well want to know whether insiders have been buying or selling shares in Allscripts Healthcare Solutions, Inc. … Check out our latest analysis for Allscripts Healthcare Solutions Allscripts Healthcare Solutions Insider Transactions Over The Last Year In the last twelve months, the biggest single sale by an insider was when the President, Richard Poulton, sold US$589k worth of shares at a price of US$9.86 per share. … NasdaqGS:MDRX Recent Insider Trading, August 13th 2019 Does Allscripts Healthcare Solutions Boast High Insider Ownership?

Simply Wall St -

What Is Allscripts Healthcare Solutions, Inc.'s (NASDAQ:MDRX) Share Price Doing?

See our latest analysis for Allscripts Healthcare Solutions Is Allscripts Healthcare Solutions still cheap? … According to my valuation model, Allscripts Healthcare Solutions seems to be fairly priced at around 3.7% below my intrinsic value, which means if you buy Allscripts Healthcare Solutions today, you’d be paying a fair price for it. … This is because Allscripts Healthcare Solutions’s beta (a measure of share price volatility) is high, meaning its price movements will be exaggerated relative to the rest of the market.

Simply Wall St -

Is Allscripts Healthcare Solutions, Inc.'s (NASDAQ:MDRX) CEO Overpaid Relative To Its Peers?

See our latest analysis for Allscripts Healthcare Solutions How Does Paul Black's Compensation Compare With Similar Sized Companies? … We compared the total CEO remuneration paid by Allscripts Healthcare Solutions, Inc., and compared it to remuneration at a group of similar sized companies. … If you think CEO compensation levels are interesting you will probably really like this free visualization of insider trading at Allscripts Healthcare Solutions.

Simply Wall St -

Is Allscripts Healthcare Solutions, Inc.'s (NASDAQ:MDRX) Stock Available For A Good Price After Accounting For Growth?

Allscripts Healthcare Solutions's extremely high growth potential in the near future is attracting investors. … However, since Allscripts Healthcare Solutions is a high-growth stock, we must also account for its earnings growth by using calculation called the PEG ratio. … A PE ratio of 51.89x and expected year-on-year earnings growth of 43% give Allscripts Healthcare Solutions a higher PEG ratio of 1.21x.

Simply Wall St -

Calculating The Intrinsic Value Of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX)

Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. … Generally we assume that a dollar today is more valuable than a dollar in the future, and so the sum of these future cash flows is then discounted to today's value: 10-year free cash flow (FCF) forecast 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 Levered FCF ($, Millions) $86.10 $86.08 $142.30 $165.65 $180.10 $192.12 $202.67 $212.12 $220.78 $228.90 Growth Rate Estimate Source Analyst x4 Analyst x4 Analyst x2 Analyst x2 Analyst x2 Est @ 6.67% Est @ 5.49% Est @ 4.66% Est @ 4.08% Est @ 3.68% Present Value ($, Millions) Discounted @ 11.68% $77.10 $69.02 $102.17 $106.50 $103.68 $99.04 $93.55 $87.68 $81.72 $75.86 Present Value of 10-year Cash Flow (PVCF)= $896.33m "Est" = FCF growth rate estimated by Simply Wall St We now need to calculate the Terminal Value, which accounts for all the future cash flows after this ten year period. … Terminal Value (TV) = FCF2029 × (1 + g) ÷ (r – g) = US$229m × (1 + 2.7%) ÷ (11.7% – 2.7%) = US$2.6b Present Value of Terminal Value (PVTV) = TV / (1 + r)10 = $US$2.6b ÷ ( 1 + 11.7%)10 = $871.17m The total value, or equity value, is then the sum of the present value of the future cash flows, which in this case is $1.77b.

Simply Wall St -

What Does Allscripts Healthcare Solutions, Inc.'s (NASDAQ:MDRX) Balance Sheet Tell Us About It?

(NASDAQ:MDRX) is a small-cap stock with a market capitalization of US$1.7b. … While investors primarily focus on the growth potential and competitive landscape of the small-cap companies, they end up ignoring a key aspect, which could be the biggest threat to its existence: its financial health. … Assessing first and foremost the financial health is

Simply Wall St -

Should You Be Concerned About Allscripts Healthcare Solutions, Inc.'s (NASDAQ:MDRX) Historical Volatility?

(NASDAQ:MDRX), then you might want to consider its beta (a measure of share price volatility) in order to understand how the stock could impact your portfolio. … Modern finance theory considers volatility to be a measure of risk, and there are two main types of price volatility. … Beta can be a useful tool to understand how much a stock is influenced by market risk (volatility).

Simply Wall St -

With A 0.8% Return On Equity, Is Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) A Quality Stock?

By way of learning-by-doing, we'll look at ROE to gain a better understanding of Allscripts Healthcare Solutions, Inc. … Over the last twelve months Allscripts Healthcare Solutions has recorded a ROE of 0.8%. … See our latest analysis for Allscripts Healthcare Solutions?

Simply Wall St -

Is There Now An Opportunity In Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX)?

Allscripts Healthcare Solutions, Inc. … (NASDAQ:MDRX), which is in the healthcare services business, and is based in United States,. … Today I will analyse the most recent data on Allscripts Healthcare Solutions’s outlook and valuation to see if the opportunity still exists

Simply Wall St -

MDRX Company Info

Description

Allscripts Healthcare Solutions, Inc. provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions. The company operates in two segments, Clinical and Financial Solutions and Population Health. The Clinical and Financial Solutions segment provides integrated clinical software applications and financial and information solutions, which primarily include EHR-related software, connectivity and coordinated care solutions, and financial and practice management software solutions, as well as related installation, support and maintenance, outsourcing, private cloud hosting, revenue cycle management, training, and electronic claims administration services. The Population Health segment offers health management, and financial management and patient engagement solutions to hospitals, health systems, accountable care organizations, and other care facilities. The company serves physicians, hospitals, governments, health systems, health plans, life-sciences companies, retail clinics, retail pharmacies, pharmacy benefit managers, insurance companies, and employer wellness clinics, as well as post-acute organizations, such as home health and hospice agencies. Allscripts Healthcare Solutions, Inc. was founded in 1986 and is headquartered in Chicago, Illinois.

Details
Name: Allscripts Healthcare Solutions, Inc.
MDRX
Exchange: NasdaqGS
Founded: 1986
$1,049,420,934
162,700,920
Website: http://www.allscripts.com
Address: Allscripts Healthcare Solutions, Inc.
222 Merchandise Mart Plaza,
Suite 2024,
Chicago,
Illinois, 60654,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NasdaqGS MDRX Common Shares Nasdaq Global Select US USD 14. Mar 2006
DB AL21 Common Shares Deutsche Boerse AG DE EUR 14. Mar 2006
Number of employees
Current staff
Staff numbers
9,600
Allscripts Healthcare Solutions employees.
Industry
Health Care Technology
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/04/03 03:45
End of day share price update: 2020/04/02 00:00
Last estimates confirmation: 2020/03/31
Last earnings filing: 2020/03/02
Last earnings reported: 2019/12/31
Last annual earnings reported: 2019/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.